Human Metabolome Technologies, Inc. (JP:6090) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Human Metabolome Technologies, Inc. reports a slight increase in net sales and operating profit for June 2024 compared to the previous year, but a significant decrease in profit attributable to owners. The company’s total assets grew, yet the capital adequacy ratio and return on equity saw a slight decline. Cash flow from operations decreased, but there was an overall rise in cash and equivalents by the end of the period.
For further insights into JP:6090 stock, check out TipRanks’ Stock Analysis page.